Cited by 37Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsPARP inhibition in cancer therapy

Accelerated Aging during Chronic Oxidative Stress: A Role for PARP-1

Open access
Boesten, Daniëlle M. P. H. J., de Vos-Houben, Joyce M. J., Timmermans, Leen, den Hartog, Gertjan J. M., Bast, Aalt, Hageman, Geja J.·2013·Oxidative Medicine and Cellular Longevity

Abstract

Oxidative stress plays a major role in the pathophysiology of chronic inflammatory disease and it has also been linked to accelerated telomere shortening. Telomeres are specialized structures at the ends of linear chromosomes that protect these ends from degradation and fusion. Telomeres shorten with each cell division eventually leading to cellular senescence. Research has shown that poly(ADP-ribose) polymerase-1 (PARP-1) and subtelomeric methylation play a role in telomere stability. We hypothesized that PARP-1 plays a role in accelerated aging in chronic inflammatory diseases due to its role as coactivator of NF-κ b and AP-1. Therefore we evaluated the effect of chronic PARP-1 inhibition (by fisetin and minocycline) in human fibroblasts (HF) cultured under normal conditions and under conditions of chronic oxidative stress, induced by tert-butyl hydroperoxide (t-BHP). Results showed that PARP-1 inhibition under normal culturing conditions accelerated the rate of telomere shortening. However, under conditions of chronic oxidative stress, PARP-1 inhibition did not show accelerated telomere shortening. We also observed a strong correlation between telomere length and subtelomeric methylation status of HF cells. We conclude that chronic PARP-1 inhibition appears to be beneficial in conditions of chronic oxidative stress but may be detrimental under relatively normal conditions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2013/680414

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Fisetin is protective when administered in the presence of OS, but if given chronically in physiological conditions, it may cause telomere shortening and promote senescence.

    “If on the one hand fisetin is protective when administered in the presence of OS, if it is given chronically in physiological conditions, it may even cause telomere shortening, therefore promoting senescence [275].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Boesten, D. M. P. H. J., de Vos-Houben, J. M. J., Timmermans, L., den Hartog, G. J. M., Bast, A., & Hageman, G. J.
Affiliations
  • Maastricht University (NL)
  • Department of Toxicology, Maastricht University, P.O. Box 6200 MD, Maastricht, The Netherlands
Corresponding author
Boesten, Daniëlle M. P. H. J.
Venue
Oxidative Medicine and Cellular Longevity
Publisher
Wiley
Published
2013
Volume
2013
Pages
1-10
ISSN
  • 1942-0994 (ISSN-L)
  • 1942-0900
OpenAlex
W2154476866
Cited by
37
References
69
Citations by year
2025: 1 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 6 · 2019: 4 · 2018: 3 · 2017: 2 · 2016: 4 · 2015: 4 · 2014: 4
FWCI
2.78
Type
journal article
Language
en
Open access
Locations
  • Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
Keywords
PARP1, accelerated aging, chronic oxidative stress, telomere shortening, telomere stability, PARP1 inhibition, fisetin, minocycline, tert-butyl hydroperoxide, human fibroblasts, cellular senescence, chronic inflammatory diseases, NF-κB, AP-1
MeSH terms
Poly (ADP-Ribose) Polymerase-1, Chromosomes, Human, Pair 2, Fibroblasts, Flavonoids, HeLa Cells, Humans, Hydrogen Peroxide, Minocycline, Poly Adenosine Diphosphate Ribose, Poly(ADP-ribose) Polymerases, Telomere, Cellular Senescence, Oxidative Stress, Telomerase, DNA Methylation, tert-Butylhydroperoxide, Flavonols, Telomere Homeostasis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review